Navigation Links
Spacebound bacteria inspire earthbound remedies
Date:3/21/2011

WASHINGTON -- Recent research aboard the Space Shuttle is giving scientists a better understanding of how infectious disease occurs in space and could someday improve astronaut health and provide novel treatments for people on Earth.

The research involves an opportunistic pathogen known as Pseudomonas aeruginosa, the same bacterium that caused astronaut Fred Haise to become sick during the Apollo 13 mission to the moon in 1970.

Scientists studying the bacterium aboard the Shuttle hope to unlock the mysteries of how disease-causing agents work. They believe the research can lead to advanced vaccines and therapies to better fight infections. The findings are based on flight experiments with microbial pathogens on NASA space shuttle missions to the station and appear in a recent edition of the journal Applied and Environmental Microbiology.

"For the first time, we're able to see that two very different species of bacteria - Salmonella and Pseudomonas - share the same basic regulating mechanism, or master control switch, that micro-manages many of the microbes' responses to the spaceflight environment," said Cheryl Nickerson, associate professor at the Center for Infectious Diseases and Vaccinology, the Biodesign Institute at Arizona State University (ASU) in Tempe. "We have shown that spaceflight affects common regulators in both bacteria that invariably cause disease in healthy individuals [Salmonella] and those that cause disease only in people with compromised immune systems [Pseudomonas]."

By studying the global gene expression patterns in bacterial pathogens like Pseudomonas and Salmonella, Nickerson's team learned more about how they react to reduced gravity.

Pseudomonas aeruginosa can coexist as a benign microbe in healthy individuals, but poses a serious threat to people with compromised immune systems. It is the leading cause of death for those suffering from cystic fibrosis and is a serious risk to burn victims. However, a high enough dosage of Salmonella typhimurium always will cause disease, even in healthy individuals.

During the initial study in 2006, two bacterial pathogens, Salmonella typhimurium and Pseudomonas aeruginosa, and one fungal pathogen, Candida albicans, were launched to the station aboard space shuttles. They were allowed to grow in appropriately contained vessels for several days. Nickerson's team was the first to evaluate global gene and protein expression (how the bacteria react at the molecular level) and virulence changes in microbes in response to reduced gravity.

"We discovered that aspects of the environment that microbes encountered during spaceflight appeared to mimic key conditions that pathogens normally encounter in our bodies during the natural course of infection, particularly in the respiratory system, gastrointestinal system and urogenital tract," Nickerson said. NASA's Advanced Capabilities Division Director, Benjamin Neumann added that, "This means that in addition to safeguarding future space travelers, such research may aid the quest for better therapeutics against pathogens here on Earth."

The initial study and follow-on space experiments show that spaceflight creates a low fluid shear environment, where liquids exert little force as they flow over the surface of cells. The low fluid shear environment of spaceflight affects the molecular genetic regulators that can make microbes more infectious. These same regulators might function in a similar way to regulate microbial virulence during the course of infection in the human body.

"We have now shown that spaceflight conditions modified molecular pathways that are known to be involved in the virulence of Pseudomonas aeruginosa," said Aurlie Crabb, a researcher in Dr. Nickerson's lab at ASU and the lead author of the paper. "Future work will establish whether Pseudomonas also exhibits increased virulence following spaceflight as did Salmonella."


'/>"/>

Contact: Joe Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University
Source:Eurekalert  

Related medicine news :

1. Gut Bacteria May Spur Obesity, Research Suggests
2. FDA to Re-examine Anti-Bacterial Chemical in Soaps, Cleansers
3. Gut bacteria offer new insights -- and hope -- for people with celiac disease
4. FDA Found Bacteria in Ingredients for Recalled Tylenol, Benadryl
5. Acne is Killed by Using Same Formula that Nature Uses to Keep Our Eyes Free from Bacteria
6. Suppressing activity of common intestinal bacteria reduces tumor growth
7. FemFlora Reformulated with New Complex of Probiotic Bacteria
8. Bacteria May Predict Chances of Colon Cancer
9. Bacteria as a predicter of colorectal cancer
10. Understanding the relationship between bacteria and obesity
11. JAN-PRO Launches Exclusive “EnviroShield™” Disinfecting System - Kills Harmful Bacteria, Including MRSA
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Spacebound bacteria inspire earthbound remedies
(Date:1/16/2017)... New York (PRWEB) , ... January 16, 2017 ... ... SightMD today announced the addition of Victor Giamos, MD to their ... of SightMD and Managing Partner at North Shore Eye Care, a division of ...
(Date:1/16/2017)... , ... January 16, 2017 , ... ... availability of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:1/16/2017)... ... ... St. Louisans are well-aware of the following facts at present:, ... be having no effect on keeping this particularly bad strain of the flu away , ... sneezing, or sniffling , These facts are well-known among the team at ...
(Date:1/16/2017)... Beverly Hills, CA (PRWEB) , ... January 16, ... ... published a manuscript in the Aesthetic Surgery Journal , the official journal ... study he conducted on lower eyelid retraction surgery. The procedure is designed to ...
(Date:1/16/2017)... ... January 16, 2017 , ... One thing common to all types ... to test for, as well. The money spent screening for and treating cancer in ... U.S. screen patients for cancer more than in any other country that has an ...
Breaking Medicine News(10 mins):
(Date:1/13/2017)... , January 13, 2017 This ... see how they have fared at yesterday,s closing bell: ... Biopharma Inc. (NASDAQ: GALE ), and ACADIA ... harness cellular and biomolecular processes to develop technologies and ... environmental footprint, feed the hungry, use less and cleaner ...
(Date:1/13/2017)... 2017 The 2016 election resulted in ... states voting in favor of legalizing cannabis for recreational use, ... in the U.S. In addition, the state of ... cannabis products sales. The ArcView Group has published an updated ... cannabis sales in the U.S. last year reached $6.7 billion, a ...
(Date:1/13/2017)... 2017   JDRF , the leading global ... pleased to announce that after more than a ... & Medicaid Services (CMS) has recognized continuous glucose ... use in making diabetes treatment decisions as durable ... eligible for coverage under Medicare. JDRF has been ...
Breaking Medicine Technology: